SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000868278-24-000010
Filing Date
2024-08-14
Accepted
2024-08-14 17:09:31
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prph-20240630.htm   iXBRL 10-Q 1039687
2 EX-31.1 prph-20240630xexx311.htm EX-31.1 10933
3 EX-31.2 prph-20240630xexx312.htm EX-31.2 11094
4 EX-32.1 prph-20240630xexx321.htm EX-32.1 5291
5 EX-32.2 prph-20240630xexx322.htm EX-32.2 5481
  Complete submission text file 0000868278-24-000010.txt   6317229

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prph-20240630.xsd EX-101.SCH 46663
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prph-20240630_cal.xml EX-101.CAL 94256
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prph-20240630_def.xml EX-101.DEF 200093
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prph-20240630_lab.xml EX-101.LAB 611294
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prph-20240630_pre.xml EX-101.PRE 397042
67 EXTRACTED XBRL INSTANCE DOCUMENT prph-20240630_htm.xml XML 745398
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 241209427
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)